Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Market Cap
$66.28M
Net Profit Margin
-33044.00%
TTM Avg
-18819.13%
3Y Avg
-12177.01%
5Y Avg
-8726.92%
Market Cap
$66.16M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-205.11%
5Y Avg
-156.77%
Market Cap
$68.08M
Net Profit Margin
-1.87%
TTM Avg
3.14%
3Y Avg
-4.53%
5Y Avg
-2.69%
Market Cap
$68.40M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$68.60M
Net Profit Margin
163.32%
TTM Avg
-34.49%
3Y Avg
-63.76%
5Y Avg
-75.19%
Market Cap
$64.53M
Net Profit Margin
-235.00%
TTM Avg
-200.38%
3Y Avg
-100.19%
5Y Avg
-66.80%
Market Cap
$69.48M
Net Profit Margin
17.18%
TTM Avg
-64.27%
3Y Avg
-50.52%
5Y Avg
-660.79%
Market Cap
$63.97M
Net Profit Margin
-621.71%
TTM Avg
-10746.07%
3Y Avg
-5373.04%
5Y Avg
-3582.02%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $67.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| iBio, Inc. (IBIO)vs › | $66.28M | -33044.00% | -18819.13% | -12177.01% | -8726.92% |
| XBiotech Inc. (XBIT)vs › | $66.16M | 0.00% | 0.00% | -205.11% | -156.77% |
| Champions Oncology, Inc. (CSBR)vs › | $68.08M | -1.87% | 3.14% | -4.53% | -2.69% |
| Tiziana Life Sciences Ltd (TLSA)vs › | $68.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 163.32% | -34.49% | -63.76% | -75.19% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.53M | -235.00% | -200.38% | -100.19% | -66.80% |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | 17.18% | -64.27% | -50.52% | -660.79% |
| RenovoRx, Inc. (RNXT)vs › | $63.97M | -621.71% | -10746.07% | -5373.04% | -3582.02% |
| Alps Group Inc (ALPS)vs › | $63.58M | -41.36% | -52.43% | -63.29% | -45.57% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
